trial · primary record
Fosmanogepix IV infusion
Invasive Mold Infections
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 234 |
| Primary completion | 2028-02 |
| Primary endpoint | Day 42 all-cause mortality rate |
| Registry ID | NCT06925321 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:07.170Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06925321
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.